Join us for a one-hour virtual roundtable where leaders from North American pharmaceutical and medical technology companies will tackle the most pressing supply chain decarbonization challenges facing the industry today. The stakes are clear: Scope 3 emissions represent the majority of pharma carbon footprints, regulatory pressure is intensifying, and investors are demanding verifiable progress. This roundtable will help you cut through the noise and identify where to act first. ERM is bringing together a panel of pharma and medical technology leaders for an open, solution-driven discussion that goes beyond theory—focusing on practical, business value driven decarbonization strategies across complex, global supply chains.
Our client speakers may explore the following topics:
- Quantifying the Financial Case for Supply Chain Decarbonization: Translate emissions reduction targets into capital allocation decisions, cost avoidance, and risk-adjusted returns.
- Scope 3 Data at Scale: Overcome supplier data gaps and build defensible, audit-ready emissions inventories across tier 1 and beyond.
- Supplier Engagement That Delivers: Move past questionnaires and build supplier decarbonization programs that drive measurable reductions without disrupting supply continuity.
- Green Procurement as a Lever: Leverage purchasing power to accelerate supplier transitions and align procurement strategy with science-based targets (SBTs).
- Cold Chain and Logistics Decarbonization: Identify practical near-term interventions in temperature-controlled distribution, last-mile logistics, and freight modal shifts.
- Regulatory Readiness: Navigate the real and present disclosure obligations shaping North American pharma, including California's SB 253 and SB 261 climate disclosure laws, CSRD supply chain requirements for companies with EU operations, and investor-driven expectations that are accelerating faster than regulation.
Don't miss this opportunity to learn from ERM's moderator Suha Gillani, Director for Private Markets Value Creation, and your industry peers. Share what's working, identify where organizations are stuck, and leave with a clearer view of your next commercial move.
